HAART in HIV-1-infected individuals has a broad spectrum of clinical outcomes. In the
majority of patients, plasma viral load becomes undetectable and CD4+ T-cells increase …

In individuals diagnosed with AIDS, the primary method of sustained suppression of HIV-1
replication is antiretroviral therapy, which systematically increases CD4+ T cell levels and …

Background. Adolescents represent the fastest growing demographic group of new human
immunodeficiency virus (HIV) infections in the United States. At present, there is little …

Suspicion that host genetic factors determine variability in the course of natural HIV-1
infection deepened throughout the 1980s and early 1990s [1, 2], but only relatively recently …

Data from basic science and clinical studies suggest that hydroxyurea (hydroxycarbamide)-
based regimens are effective treatment options for patients with HIV at various stages of …

Background Viral load (VL) is recommended for monitoring the response to highly active
antiretroviral therapy (HAART) but is not routinely available in most low-and middle-income …

Medicine Log in or Register Get new issue alertsGet alerts Secondary Logo Journal Logo
Advanced Search Toggle navigation Register Login Articles & Issues Browse by Specialty …

Background. In recent years, treatment options for human immunodeficiency virus type 1
(HIV-1) infection have changed from nonboosted protease inhibitors (PIs) to nonnucleoside …

Lymphocyte subsets, activation markers and apoptosis were assessed in 20 HIV-exposed
noninfected (ENI) children born to HIV-infected women who were or not exposed to …

Objective: New treatments introduced in the mid-1990s led many people with HIV/AIDS who
previously had been disabled by their disease to contemplate workforce reentry; many …